Our medicines

Juluca

JULUCA

JULUCA is indicated for the treatment of HIV-1 infection in adults who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6 months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.

TRIUMEQ

TRIUMEQ does not cure HIV infection: it reduces the amount of the virus in the patient's body, and keeps it at a low level. TRIUMEQ also increases the CD4 cell count in their blood. CD4 cells are a type of white blood cell that are important in helping our bodies to fight infection.

TIVICAY

TIVICAY does not cure HIV infection; it reduces the amount of virus in the patient's body, and keeps it at a low level. TIVICAY also increases the CD4 cell count in their blood. CD4 cells are a type of white blood cell that are important in helping our bodies to fight infection.

 

TIVICAY is used, in combination with other anti-retroviral medicines (combination therapy), to treat HIV infection in adults and children over 12 years old. 

Other Medicines

For full Product Information and Consumer Medicine Information for ViiV Healthcare’s other medicines, please visit  
https://www.viivhealthcare.com.au/our-medicines/

 

Speak To A VIIV Healthcare representative

Arrange an appointment with a ViiV Healthcare team member to discuss clinical data and medical information

Contact Us